Search

everythinglearnresearchcommunity

for

Search:↓

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Perhexiline can effectively target ovarian cancer cells left after treatment.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

PRP treatments for hair loss need standard protocols to be reliable.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Hair repigmentation can indicate malignancy and should be investigated.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Patients with this syndrome can have different responses and worsening resistance to treatment over time.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Trichoblastoma in the breast can be mistaken for cancer, so expert review is crucial to avoid misdiagnosis.

Prenatal retinoic acid exposure did not affect mouse vibrissal follicle development.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

PLD is an effective and safer alternative for treating breast cancer.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The combination treatment showed a higher response rate but no significant survival benefits.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Analog 23 is a promising compound for prostate cancer treatment.